Jonathan Rubin
Chief Tech/Sci/R&D Officer chez SUPERNUS PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Jonathan Rubin's current job is Senior VP-R&D, Chief Medical Officer at Supernus Pharmaceuticals, Inc. Dr. Rubin's former jobs include being a Medical Director at Shire Development LLC, Chief Medical Officer at Alcobra Ltd.
from 2013 to 2017, and Chief Medical Officer at Atentiv, Inc. from 2018 to 2020.
Dr. Rubin's education includes an undergraduate degree from Yale University, an MBA from Columbia Business School, and a doctorate from The University of Connecticut School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ASHTROM GROUP LTD.
0,14% | 29/06/2023 | 144 849 ( 0,14% ) | 2 M $ | 31/03/2024 |
23/02/2024 | 4 641 ( 0,01% ) | 158 305 $ | 31/03/2024 |
Postes actifs de Jonathan Rubin
Sociétés | Poste | Début |
---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Anciens postes connus de Jonathan Rubin
Sociétés | Poste | Fin |
---|---|---|
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/02/2020 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
Shire Development LLC | Chief Tech/Sci/R&D Officer | - |
Formation de Jonathan Rubin
Yale University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
The University of Connecticut School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Shire Development LLC | |
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Technology Services |